BRCA 2020

A Vision of the Future

The 8thInternational Symposium on Hereditary Breast and Ovarian Cancer

May 5-8, 2020

Centre Mont-Royal, Montréal, Québec, Canada


JOIN WITH

Colleagues, clinicians and researchers from over 25 countries – for the eighth edition of this event which has come to be recognized as one of the leading international scientific conferences on hereditary cancer.

EXPERIENCE

Eureka moments, stimulating exchanges and valuable networking opportunities with colleagues from across North America and abroad.

DISCOVER

Practical insights to increase your understanding of the issues and to learn about new developments in BRCA 1/2 research and clinical care options.



Marla Miller Memorial Lecture

Kári Stefánsson
Founder and CEO, deCODE Genetics
Reykjavík, Iceland


Awesome Speakers

Stephen Chanock
Director, National Cancer Institute, Rockville, MD, USA
Fergus Couch
Professor of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA



Ephrat Levy-Lahad
Director, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel
Steven Narod
Canada Research Chair in Breast Cancer,
Women’s College Research Institute / University of Toronto, Toronto, ON, Canada



Mark Robson
Chief, Breast Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Clare Turnbull
Clinical Lead at 100,000 Genomes Project Cancer Programme,
Genomics England and Institute of Cancer Research, London, UK;


What's been said...

‘This is such a wonderful way to learn! ’

‘Incredible knowledge sharing. ’

‘Impressive speaker line-up, they truly are key thought leaders in the field.’

‘The level of research and researchers was impressive.’

‘I appreciated the mix of basic science, clinical application & psychosocial lectures. ’

‘Very stimulating to have so many international attendees. Interesting to see differences in practice & approaches to genetic testing. ’

‘Interdisciplinary attendance, really interesting to have bench to bedside represented.’

‘Format was stellar - plenty of time for learning, questions, debate, rest.’

‘Spectacular conference! I can't think of anything else to say!!’

‘Honestly one of the best conferences I've ever been to!!’

‘Near perfect! ’

‘I am a convert; will attend again. ’

‘Well worth the trip & time out of clinic.’

WHO SHOULD ATTEND
Primary care physicians, specialist physicians, laboratory researchers, nurses and genetic counsellors
who are interested in furthering their knowledge in the field of hereditary breast and ovarian cancer.
11 FULL SESSIONS
  • Mutations, variants, databases
  • Pathology – Clinical relevance
  • Applied functional and computational genetics
  • Population-based approaches to genetic testing and risk assessment
  • Plus many more...
Plus...
Full-Day Conference for the General Public
Proffered Papers selected from abstracts
Poster Sessions
And much, much more...

Make Connections

Join with more than 600 colleagues and experts from North America, Europe and beyond

Mix and mingle with newfound colleagues and old friends.

OUR KIND SPONSORS